<p>After RSV B (KR/B/10-12) challenge, all mice (n = 4/group) were sacrificed and lung mononuclear cells were isolated 5 days post-infection. Lung lymphocytes were stimulated and were analyzed as the same manner as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0175384#pone.0175384.g004" target="_blank">Fig 4</a>. (A) CD3<sup>+</sup> and CD4<sup>+</sup> cells are shown in the dot plots, (B) and the percentage of such cells is represented as the frequency of RSV G-specific IFN-γ<sup>+</sup> and IL-17A<sup>+</sup> CD4 T cells. Data are represented in mean ± SD (n = 4/group). Significant differences are marked with a hash tag (#, <i>p < 0</i>.<i>05</i>).</p
AbstractVaccination with the respiratory syncytial virus (RSV) attachment (G) protein results in imm...
<p>RSV-infected mice were treated with suboptimal doses of either anti-G mAb (130-6D, 150 µg/mouse) ...
Vaccination with the respiratory syncytial virus (RSV) attachment (G) protein results in immune-medi...
<p>BALB/c mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). CD3<sup>+</sup> gated, CD4<su...
<p>Six days after infection, single cell suspensions of lungs from control (Cont), RSV-infected (RSV...
<p>BALB/c mice and IL-10<sup>−/−</sup> mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). ...
<p>Mice were immunized with the indicated RSV sF (0.3 μg) vaccine formulations at days 0 and 14 or w...
<p>The number of G<sub>183</sub>-specific (grey bars) and M2<sub>82</sub>-specific (black bars) IL-4...
<p>Mice were vaccinated with 50 µg of RSV G nanoparticles, 10 µg of purified G protein emulsified 1:...
<p>(A) Mice were immunized twice with Gcf s.l., once with FI-RSV by food-pad injection, or 1×10<sup>...
<p>BALB/c mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). Where indicated, mice were in...
<p>Mice (n = 7 per group) were immunized at days 0 and 14 with the indicated vaccines and challenged...
<p>(A) Mice received IP injections of anti-IL-17A antibody or isotype control antibody upon and two ...
<p>Immunized mice were vaccinated intranasally (i.n.) twice at day 0 and day 28 with NE-RSV (10<sup>...
<p>RSV-specific cellular immune responses in AGMs at 28 days following infection were determined by ...
AbstractVaccination with the respiratory syncytial virus (RSV) attachment (G) protein results in imm...
<p>RSV-infected mice were treated with suboptimal doses of either anti-G mAb (130-6D, 150 µg/mouse) ...
Vaccination with the respiratory syncytial virus (RSV) attachment (G) protein results in immune-medi...
<p>BALB/c mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). CD3<sup>+</sup> gated, CD4<su...
<p>Six days after infection, single cell suspensions of lungs from control (Cont), RSV-infected (RSV...
<p>BALB/c mice and IL-10<sup>−/−</sup> mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). ...
<p>Mice were immunized with the indicated RSV sF (0.3 μg) vaccine formulations at days 0 and 14 or w...
<p>The number of G<sub>183</sub>-specific (grey bars) and M2<sub>82</sub>-specific (black bars) IL-4...
<p>Mice were vaccinated with 50 µg of RSV G nanoparticles, 10 µg of purified G protein emulsified 1:...
<p>(A) Mice were immunized twice with Gcf s.l., once with FI-RSV by food-pad injection, or 1×10<sup>...
<p>BALB/c mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). Where indicated, mice were in...
<p>Mice (n = 7 per group) were immunized at days 0 and 14 with the indicated vaccines and challenged...
<p>(A) Mice received IP injections of anti-IL-17A antibody or isotype control antibody upon and two ...
<p>Immunized mice were vaccinated intranasally (i.n.) twice at day 0 and day 28 with NE-RSV (10<sup>...
<p>RSV-specific cellular immune responses in AGMs at 28 days following infection were determined by ...
AbstractVaccination with the respiratory syncytial virus (RSV) attachment (G) protein results in imm...
<p>RSV-infected mice were treated with suboptimal doses of either anti-G mAb (130-6D, 150 µg/mouse) ...
Vaccination with the respiratory syncytial virus (RSV) attachment (G) protein results in immune-medi...